首页 | 本学科首页   官方微博 | 高级检索  
检索        

日本血吸虫双价DNA疫苗pVIV02-Sj14-Sj23免疫方案的研究
引用本文:艾熙,夏丽霞,谢姣,胡媛,石佑恩.日本血吸虫双价DNA疫苗pVIV02-Sj14-Sj23免疫方案的研究[J].中国血吸虫病防治杂志,2007,19(3):175-178.
作者姓名:艾熙  夏丽霞  谢姣  胡媛  石佑恩
作者单位:1华中科技大学同济医学院02级七年制学生(武汉430030);2华中科技大学同济医学院病原生物学系
摘    要:目的研究双价DNA疫苗pVIV02-Sj14-Sj23在不同免疫剂量、免疫次数、免疫有效时间及不同免疫途径的最佳免疫方案。方法 构建和制备双价DNA疫苗pVIV02-Sj14-Sj23;110只雄性BALB/c小鼠随机分成11组,每组10只,按照四因素三水平分成2个对照组和9个实验组。各组统一在末次免疫后30 d每鼠感染(40士2)条日本血吸虫尾蚴,感染后45 d剖杀,计数成虫虫荷。结果双价DNA疫苗9个实验组获得40.14%~62. 68%的减虫率。通过SPSS 12.O进行正交设计的统计分析:F值O. 05。免疫剂量,免疫次数,免疫途径和免疫有效时间几个因素间差异无统计学意义。结论实验结果提示该疫苗的较好免疫方案为:50 Vg/只,免疫2次,采取皮内注射,免疫有效时间至少为12周。

关 键 词:,日本血吸虫,双价DNA疫苗,Sj14,Sj23,免疫方案,

Studies on the optimal bivalent DNA vaccine immunization of Schistosoma japonicum
Ai Xi.Xia Li-xia,Xie Jiao,Hu Yuan,Shi You-en.Studies on the optimal bivalent DNA vaccine immunization of Schistosoma japonicum[J].Chinese Journal of Schistosomiasis Control,2007,19(3):175-178.
Authors:Ai XiXia Li-xia  Xie Jiao  Hu Yuan  Shi You-en
Abstract: Objective   To study the optimal immunization of bivalent DNA vaccine encoding Schistosoma japonicum 14 kDa (Sj14) and 23 kDa (Sj23) with the different immunized dosages, in- oculated times, inoculated routes and challenge time after the last immunization. Methods  Con- struction and preparation of the bivalent DNA vaccine of Schistosoma  japonicum 14 kDa (Sj14) and 23 kDa(Sj23) were porformed. A total of 110 male BALB/c mice, about 5-6 weeks old, were ran- domly divided int0 11 groups,2 were the control groups and 9 were the experimental groups, de- signed with four factors in orthogonal trial.  Each mouse of the groups was infected with (40± 2) cercariaes of Schistosoma japonicum in the 30 th day after last immunization, and 45 days after the infection, the mice were sacrificed, and the burden of the adult worms was invetigated. Results There was no significant difference in the impact on immunity protection excited by the different fac- tors and different levels of each factor (P>O. 05).  Conclusion   According to this experiment, the optimal immunization for this vaccine is 50 ptg per mouse, twice immunization and intradermal injec- tion, and the period of efficacy is at least 12 weeks after the challenge.
Keywords:   Schistosoma japonicum  Bivalent DNA vaccine  Sj14  Sj23  Optimal immunization
点击此处可从《中国血吸虫病防治杂志》浏览原始摘要信息
点击此处可从《中国血吸虫病防治杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号